​

Protagenic Therapeutics (PTIX) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChartTranscripts

Protagenic Therapeutics Revenue Highlights

0

Latest Revenue (Q)

$50.29K

Protagenic Therapeutics Revenue by Period

Protagenic Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-06-30-100.00%
2014-06-30--100.00%
2013-06-30$85.00K-99.79%
2010-12-31$40.03M-42.07%
2009-12-31$69.09M-39.33%
2008-12-31$113.88M207.94%
2007-12-31$36.98M97.54%
2006-12-31$18.72M100.00%
2005-07-31-100.00%
2004-07-31-100.00%
2003-07-31--100.00%
2002-07-31$18.57M-14.12%
2001-07-31$21.63M1.11%
2000-07-31$21.39M13.99%
1999-07-31$18.76M20.16%
1998-07-31$15.62M24.19%
1997-07-31$12.57M27.00%
1996-07-31$9.90M43.48%
1995-07-31$6.90M-

Protagenic Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Protagenic Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30$50.29K100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$3.20K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31--100.00%
2021-12-31$-480.51K100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30--100.00%
2011-09-30$12.33M96.59%
2011-06-30$6.27M-11.13%
2011-03-31$7.05M-9.97%
2010-12-31$7.84M-14.61%
2010-09-30$9.18M-15.13%
2010-06-30$10.81M-11.37%
2010-03-31$12.20M-10.69%
2009-12-31$13.66M-8.16%
2009-09-30$14.87M-12.55%
2009-06-30$17.01M-27.77%
2009-03-31$23.55M2.94%
2008-12-31$22.88M-25.77%
2008-09-30$30.82M-2.01%
2008-06-30$31.45M9.44%
2008-03-31$28.74M105.99%
2007-12-31$13.95M32.93%
2007-09-30$10.49M52.23%
2007-06-30$6.89M22.19%
2007-03-31$5.64M100.00%
2006-10-31-100.00%
2006-07-31-100.00%
2006-04-30-100.00%
2006-01-31--

Protagenic Therapeutics generated $50.29K in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Protagenic Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ADAGAdagene$18.11M$833.34K
RZLTRezolute--
ANTXAN2 Therapeutics--
AVTEAerovate Therapeutics--
TPSTTempest Therapeutics--
ACRVAcrivon Therapeutics--
PTIXProtagenic Therapeutics-$50.29K
ELDNEledon Pharmaceuticals--

PTIX Revenue FAQ

What is Protagenic Therapeutics’s yearly revenue?

Protagenic Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. PTIX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Protagenic Therapeutics’s quarterly revenue?

Protagenic Therapeutics's quarterly revenue for Q3 2024 was $50.29K, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). PTIX's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is Protagenic Therapeutics’s revenue growth rate?

Protagenic Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.